 -- Preclinical findings show that ONCR-177s systemic antitumor immunity is driven by its five complementary immunomodulatory transgene payloads and retention of γ 34.5 -- -- Complete and durable tumor regression and protective antitumor memory observed in multiple syngeneic tumor models -- 